Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Mar;118(2):230-2.
doi: 10.1007/BF02245847.

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

Affiliations

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

L J Bristow et al. Psychopharmacology (Berl). 1995 Mar.

Abstract

Previous studies have demonstrated that the glycine/NMDA receptor antagonist, L-701,324 (7-chloro-4-hydroxy-3(3-phenoxy)phenyl-2(H)quinolone) blocks the activation of mesolimbic dopamine systems induced following psychostimulant administration in the rat (Bristow et al. 1994). In the present study, pretreatment with L-701,324 also reversed the deficit in prepulse inhibition (PPI) observed in rats reared in social isolation after weaning. Given that PPI is also attenuated in schizophrenic patients and that isolation rearing induces both neurochemical and behavioural abnormalities suggestive of a physiologically induced state of dopaminergic hyperactivity, these results suggest that blockade of the glycine/NMDA receptor may offer a new strategy for the development of novel antipsychotic agents.

PubMed Disclaimer

References

    1. Psychopharmacology (Berl). 1993;113(1):103-9 - PubMed
    1. Neuropsychopharmacology. 1989 Dec;2(4):299-308 - PubMed
    1. Neuroscience. 1991;41(1):1-24 - PubMed
    1. Pharmacol Biochem Behav. 1992 Sep;43(1):17-35 - PubMed
    1. J Med Chem. 1993 Oct 29;36(22):3386-96 - PubMed

LinkOut - more resources